Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS: RTSL · Delayed Price · USD
0.0015
-0.0007 (-31.82%)
Aug 30, 2024, 2:24 PM EDT - Market closed
RTSL Employees
As of December 31, 2022, Rapid Therapeutic Science Laboratories had 4 total employees, including 3 full-time and 1 part-time employees. The number of employees decreased by 4 or -50.00% compared to the previous year.
Employees
4
Change (1Y)
-4
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
$14,889
Market Cap
93.04K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 4 | -4 | -50.00% |
Dec 31, 2021 | 8 | 0 | - |
Dec 31, 2020 | 8 | 7 | 700.00% |
Mar 31, 2020 | 1 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RTSL News
- 1 year ago - White House Office of Management and Budget review on Cannabis-Derived Products confirms Rapid Therapeutic Science Laboratories' Long-Term Strategy - GlobeNewsWire
- 1 year ago - Rapid Therapeutic Science Laboratories Updates Patents - GlobeNewsWire
- 2 years ago - Rapid Therapeutic Science Laboratories File S1 and completes Mid-Year Strategy Review - GlobeNewsWire
- 3 years ago - Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference - GlobeNewsWire
- 3 years ago - Rapid Therapeutic Science Laboratories Secures Upgraded Laboratory and Manufacturing Facility - GlobeNewsWire